Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.
about
The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex InterplayPositional therapy for obstructive sleep apnoeaFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic ratsFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's diseaseHypoxia: The Force that Drives Chronic Kidney DiseaseObstructive sleep apnea and dyslipidemia: evidence and underlying mechanismChronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approachReactive oxygen species in inflammation and tissue injuryEtiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders.Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure.Pathophysiology of sleep apneaRole of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method.Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELSGlucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot studyOxidative stress in children with obstructive sleep apnea syndrome.Time course of intermittent hypoxia-induced impairments in resistance artery structure and function.Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea.Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea.Neuronal death during combined intermittent hypoxia/hypercapnia is due to mitochondrial dysfunction.Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea.Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.Sleep-disordered breathing and cardiovascular disorders.Targeting NOX enzymes in the central nervous system: therapeutic opportunities.The impact of obstructive sleep apnea on chronic kidney disease.Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients.Sleep-disordered breathing, control of breathing, respiratory muscles, pulmonary function testing, nitric oxide, and bronchoscopy in AJRCCM 2000.Sleep apnea and cardiovascular disease.Use of continuous positive airway pressure for sleep apnea in the treatment of hypertensionEndothelial dysfunction in the microcirculation of patients with obstructive sleep apnea.Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apneaLifestyle effects on hematopoiesis and atherosclerosis.Obstructive sleep apnoea/hypopnoea syndrome and hypertension.Reactive oxygen species and the brain in sleep apnea.Endothelial function in obstructive sleep apnea.Obstructive sleep apnea, inflammation, and the metabolic syndromeWhite matter damage and systemic inflammation in obstructive sleep apnea.Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitus
P2860
Q21284813-E7E469E4-7025-4DE5-8923-2F49EEFDAD96Q24200777-A7BF0A7B-EE34-43A5-B794-4D7AFAD0D79AQ26747585-15BE302F-8909-4293-8E1E-57C5073557F7Q26748713-BA1146D4-613B-4E97-B359-00E3F854E6C6Q26768865-EAEEF573-A206-4802-B291-6895CC5AAF6AQ26999248-51794B15-A3AF-4989-A0AE-689CE53A5F81Q28076146-BBBC91C4-79A5-4EF6-80BD-1875B9CC9973Q28396273-423B8E49-D9EF-4FCD-9806-EB0369EDCE91Q30419870-B5937C83-F22C-4B98-B5C6-B9B317B1962DQ30434409-1C753AB2-F1D1-48C3-92F1-1E4DD6545596Q30440658-7BB899E4-039C-4F17-8535-D2F059810262Q30455065-3168E818-BA24-4738-B49D-917D02B1F496Q30477320-5AB5FC4C-B344-4486-BF3A-D7DD394D6D60Q30494316-DEE16F2C-9A2E-43BD-96A8-B70CE5BDC72BQ33578344-7E4A43AF-CD89-421A-874B-A749A6F5080EQ33651657-E8219DEB-C751-493E-A17E-48A29C5D4531Q33652144-96C145B4-CA13-4B8B-BFAA-F9BB72013108Q33748662-55DA1638-7952-403B-AED6-A88432CA12A0Q33759579-2835FB90-6C8C-468B-A156-02C10ABDF281Q33929792-75C88F3B-7B41-4CC7-A945-517C7040C46BQ34033423-8210C0D6-DDF7-4633-9D0B-F205223F395CQ34122262-A0FE3B7C-F8BC-42EF-BE09-2CDFCAF609CAQ34273305-E90583A1-FA08-4D6B-9E9D-F106549F873FQ34285497-1E9F8155-F17C-4E48-904E-41848C593D89Q34288892-E0C3FD0E-63A3-4192-B3F2-22D8B5657D67Q34289495-5A78BDA6-B4D3-4EB0-9B56-68119D6211B4Q34325896-56732F29-85A9-424C-B7A7-7E9CEF7BA222Q34435272-9C8F4192-E7FA-493C-AA58-1D9D2EBE7BA0Q34467343-2F077A81-7EE7-4982-9A79-997C32540C7CQ34487311-5AB60FAE-DD17-45AE-8546-E3D801C58114Q34535079-E67140FD-F92C-4CCF-AD03-EE9E4C400FA4Q34622369-D489AEE3-91E0-4023-B8CC-2710D9EFF915Q34668164-6A6DF8ED-408F-4764-89E3-7EB008CBE42FQ34783095-90ADE0E9-F4E1-4C61-8809-2205523D805CQ34939523-3FF202B9-C8BF-4C3F-B7B8-4412F641C038Q35086889-ADBA040E-1146-45E4-B3DB-53DDFEFB98BDQ35104040-7C74BFE0-6B90-40D7-9C11-705EAAFD0D19Q35104910-80539FA9-9FDA-46CC-ACC3-A57AC1BA7A3BQ35219730-74C9D3B9-9D25-4B90-BBFA-7FC3B576CD7FQ35331587-7FAF14AF-CCE2-434D-B7B7-45B2B8980DD3
P2860
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Enhanced release of superoxide ...... itive airway pressure therapy.
@en
Enhanced release of superoxide ...... itive airway pressure therapy.
@nl
type
label
Enhanced release of superoxide ...... itive airway pressure therapy.
@en
Enhanced release of superoxide ...... itive airway pressure therapy.
@nl
prefLabel
Enhanced release of superoxide ...... itive airway pressure therapy.
@en
Enhanced release of superoxide ...... itive airway pressure therapy.
@nl
P2093
P2860
P1476
Enhanced release of superoxide ...... itive airway pressure therapy.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.162.2.9908091
P407
P433
P577
2000-08-01T00:00:00Z